DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathwayMeng Zhang, Junnian Zheng, Pingfu Hou et al.|Oncology Reports|2018Cited by 32
Genetically engineered macrophages reverse the immunosuppressive tumor microenvironment and improve immunotherapeutic efficacy in TNBCRanran Jiang, Gang Wang, Xin Liu et al.|Molecular Therapy|2025Cited by 16